ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,145Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 122

$566K Total Retail Price of All Prescriptions

Rank: 11 out of 122

394 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

8% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,003 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
SIMVASTATIN 387 354 1 1
LISINOPRIL 386 340 2 2
AMLODIPINE BESYLATE 307 273 3 7
OMEPRAZOLE 272 233 4 3
ATORVASTATIN CALCIUM 245 237 5 13
WARFARIN SODIUM 239 239 6 9
FUROSEMIDE 238 227 7 5
LEVOTHYROXINE SODIUM 231 216 8 4
ATENOLOL 224 208 9 10
GABAPENTIN 213 160 10 12
HYDROCHLOROTHIAZIDE 190 178 11 6
METOPROLOL TARTRATE 177 165 12 8
METFORMIN HCL 140 127 13 14
ZOLPIDEM TARTRATE 126 115 14 19
METOPROLOL SUCCINATE 117 115 15 11
SPIRIVA 115 106 16 29
ALENDRONATE SODIUM 113 113 17 35
SERTRALINE HCL 113 101 17 18
PANTOPRAZOLE SODIUM 95 95 19 23
LOSARTAN POTASSIUM 94 93 20 17
PREDNISONE 91 72 21 24
CITALOPRAM HBR 91 74 21 15
DONEPEZIL HCL 88 88 23 25
ALLOPURINOL 84 70 24 33
TRAMADOL HCL 79 61 25 20
ESCITALOPRAM OXALATE 78 75 26 59
HYDROCODONE-ACETAMINOPHEN 77 53 S3 27 16
VENLAFAXINE HCL ER 74 62 28 54
DIOVAN 73 73 29 40
TAMSULOSIN HCL 72 50 30 26
DILTIAZEM 24HR ER 70 67 31 108
CARVEDILOL 69 69 32 56
NEXIUM 65 56 33 32
LOVASTATIN 64 61 34 28
LIPITOR 62 61 35 82
FENTANYL 60 50 S2 36 47
ENALAPRIL MALEATE 60 60 36 43
OXYCODONE HCL 59 42 S2 38 30
PROPRANOLOL HCL 55 54 39 114
POTASSIUM CHLORIDE 55 46 39 22
CELEBREX 52 38 41 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.